Researchers Yusuf İlhan
Yusuf İlhan profile image
Yusuf İlhan Professional Antalya Şehir Hastanesi
Publication 3 Review 1
3 Publication
1 Review

Research Fields

Clinical Oncology Oncology and Carcinogenesis Cancer Cell Biology Cancer Diagnosis

Institution

Antalya Şehir Hastanesi

Publications

The Clinical Significance of Erythrocytic Macrocytosis in Metastatic Renal Cell Cancer and Sarcoma Patients Treated with Pazopanib
Authors: Yusuf İlhan , Mehmet Fatih Özbay , Sema Sezgin Göksu , Ali Murat Tatlı , Hasan Şenol Coşkun
Published: 2024 , Akdeniz Medical Journal
DOI: 10.53394/akd.1174869
FAVORITE 0 TOTAL DOWNLOAD COUNT 124

0

124

Prognostic significance of PNI, SIRI and LIPI in non small-cell lung cancer
Authors: Onur Yazdan Balçık , Ali Aytaç , Tugay Avcı, Bilgin Demir , Yusuf İlhan , Gökhan Karakya, Atike Pinar Erdoğan
Published: 2023 , Acta Medica Alanya
DOI: 10.30565/medalanya.1314292
FAVORITE 0 TOTAL DOWNLOAD COUNT 155

0

155

Can gustave roussy ımmune score predict the prognosis and survival in patients with operabl colorectal cancers?
Authors: Arif Hakan Onder , Yusuf İlhan , Onur Yazdan Balçık , Gökhan Karakaya
Published: 2023 , Turkish Journal of Clinics and Laboratory
DOI: 10.18663/tjcl.1324390
FAVORITE 0 TOTAL DOWNLOAD COUNT 128

0

128

Articles published in
Acta Medica Alanya
Acta Medica Alanya
Akdeniz Medical Journal
Akdeniz Medical Journal
Turkish Journal of Clinics and Laboratory
Turkish Journal of Clinics and Laboratory

Reviews

Cumhuriyet Medical Journal
Cumhuriyet Medical Journal
There are no Crossref cited.
Popular Publications: It is determined automatically by the researchers doing research in DergiPark according to the statistics of being added to the favorites. CrossRef Cited: The citations shown in DergiPark are drawn from CrossRef. For this, the cited and cited articles must be registered in CrossRef (DOI number). ^: Citation numbers are reflected in the system by DergiPark at certain periods.
Interactive Guide Tool
If you want to see the panel introduction, you can click Start Tour.